# NIAID- VRC - PREMISE - Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2022 · $880,000

## Abstract

One of the key components of the VRC mission involves the rapid advancement of promising vaccine and therapeutic candidates from the laboratory to the clinic. There is a need for supporting translational research leading to identification of new therapies or approaches in treating and preventing infectious diseases. PREMISE has been developed as a Pandemic Response Repository through Microbial and 
Immunologic Surveillance and Epidemiology, and provides detection and surveillance of novel and 
emerging pathogens and deep 
analysis of host immune responses at a population-wide scale in order to prepare for an effective response to infectious threats.

## Key facts

- **NIH application ID:** 10722411
- **Project number:** 75N91019D00024-P00001-759102200005-2
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** CHRISTOPHER CASE
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $880,000
- **Award type:** —
- **Project period:** 2022-03-04 → 2027-09-15

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10722411

## Citation

> US National Institutes of Health, RePORTER application 10722411, NIAID- VRC - PREMISE - Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology (75N91019D00024-P00001-759102200005-2). Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/grant/nih/10722411. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*